Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer
- 31 October 1998
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 22 (1) , 31-38
- https://doi.org/10.1016/s0169-5002(98)00065-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC)Annals of Oncology, 1992
- Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- Activity of high-dose epirubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Phase II study of high-dose epirubicin in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase II Study of High-Dose Epirubicin in Non-Small Cell Lung CancerPublished by S. Karger AG ,1989
- Epirubicin and doxorubicin comparative metabolism and pharmacokineticsCancer Chemotherapy and Pharmacology, 1988
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1984